Quebec health director says Omicron-targeted vaccine ready in ‘less than two weeks’
MONTREAL — A bivalent COVID-19 vaccine, which targets both the original strain of the novel coronavirus and the Omicron variant, should be available for Quebecers in less than two weeks, public health director Dr. Luc Boileau said Wednesday.
He told reporters that health centres are expected to start receiving shipments of the new vaccine within the next few days — even though Canadians are still waiting on Health Canada’s approval of bivalent vaccine submissions from Moderna and Pfizer.
The COVID-19 vaccines currently available in Canada are designed to target solely the original strain of the virus, which has continued to mutate and prove adept at evading immune detection. Boileau said Quebec would stop distributing the older-generation vaccines when it receives the new ones, which are designed to recognize specific mutations in the spike protein of the Omicron BA. 1 subvariant.
“It will be simple: when the new vaccine arrives, we will not use up the existing stocks we have of current vaccines,” Boileau said. “We’ll just move on.”


